You can buy or sell CYCN and other stocks, options, and ETFs commission-free!
Cyclerion Therapeutics, Inc. Common Stock, also called Cyclerion Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology. Read More Its product pipeline includes several sGC stimulators, a small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate (cGMP). The company was founded on September 6, 2018 and is headquartered in Cambridge, MA. The listed name for CYCN is Cyclerion Therapeutics, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 10, Pre-Market